PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Mar-2022 Evolus to Participate in the Barclays Global Healthcare Conference Businesswire
08-Mar-2022 Simulations Plus to Present at Oppenheimer Annual Healthcare Conference Businesswire
08-Mar-2022 Biocept Appoints Philippe Marchand as Chief Operating Officer Businesswire
08-Mar-2022 PROS Industry-Leading Pricing Advances Global Business Strategy for B Braun Medical Businesswire
08-Mar-2022 New, Innovative GC and GC-MS Product Portfolio Enables Greater Uptime and Efficiency Businesswire
08-Mar-2022 Palleon Pharmaceuticals Announces First Patient Dosed in Phase 1/2 Study of Lead Glyco-Immunology Drug Candidate for Oncology Businesswire
08-Mar-2022 Mytide Therapeutics Raises $7 Million Series A Round to Transform Peptide Manufacturing with Machine Learning Businesswire
08-Mar-2022 Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles Businesswire
08-Mar-2022 Genexa Named Fast Company’s No. 1 Most Innovative Company in Wellness for 2022 Businesswire
08-Mar-2022 TRexBio Completes $26 Million Series A Extension Led by Polaris Partners to Advance Treatments for Immune-Mediated Diseases Businesswire
08-Mar-2022 Variscite Subverts Component Crises with Launch of Additional Production Line Businesswire
08-Mar-2022 Aldeyra Therapeutics Initiates Phase 2 Clinical Trial of ADX-2191 for the Treatment of Retinitis Pigmentosa Businesswire
08-Mar-2022 Revance Resubmits Biologics License Application for DaxibotulinumtoxinA for Injection for Glabellar Lines to the FDA Businesswire
08-Mar-2022 Inspirna to Participate in Multiple Virtual Healthcare Investor Conferences in March Businesswire
08-Mar-2022 Cognito Therapeutics and Aetion Announce Partnership to Use Artificial Intelligence to Identify Rapidly Progressing Forms of Mild Cognitive Impairment and Alzheimer's Disease Businesswire
08-Mar-2022 Dermavant Appoints Nancy Beesley to its Board of Directors Businesswire
08-Mar-2022 Magenta Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Highlights Businesswire
08-Mar-2022 Curie Therapeutics Appoints Karen Smith, M.D., Ph.D., as Independent Board Director Businesswire
08-Mar-2022 KELIX bio Enters Into a Binding Commitment to Acquire PHI, a Leading Pharmaceutical Manufacturer in Morocco Businesswire
08-Mar-2022 Precision BioSciences to Report Fourth Quarter and Fiscal Year 2021 Results on March 15, 2022 Businesswire